Overweight and obesity as risk factors for biochemical recurrence of prostate cancer after radical prostatectomy

被引:4
|
作者
Kim, Sung Jin [1 ]
Park, Min Uk [2 ]
Chae, Han Kyu [1 ]
Nam, Wook [1 ]
Kim, So Won [3 ]
Yu, Hoon [4 ]
Kim, Han Gwun [1 ]
Kang, Gil Hyun [5 ]
Park, Jong Yeon [1 ]
机构
[1] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Urol, Kangnung, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Urol, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pharmacol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Nephrol, Kangnung, South Korea
[5] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Pathol, Kangnung, South Korea
关键词
Prostate cancer; Biochemical recurrence; Body mass index; Obesity; BODY-MASS INDEX; ANTIGEN DENSITY; ASSOCIATION; AMERICAN; MEN;
D O I
10.1007/s10147-021-02058-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Previous studies have shown a relationship between the occurrence and recurrence of prostate cancer; however, this relationship remains controversial. We investigated the relationship between obesity and biochemical recurrence in patients with prostate cancer. Methods Clinicopathological factors were analyzed after dividing the patient population according to the Asian population-specific body mass index (BMI) criteria for "normal" (< 23 kg/m(2)), "overweight" (23-27.5 kg/m(2)), and "obese" (>= 27.5 kg/m(2)). Among the 389 patients included in this study, 108 were classified as normal, while 227 and 54 patients were classified as overweight and obese, respectively. The relationships between clinicopathological factors and biochemical recurrence were analyzed by univariate and multivariate Cox <= proportional hazard models. Biochemical recurrence was defined as two consecutive prostate-specific antigen (PSA) measurements >= 0.2 ng/mL. Results In univariate analysis, the categorical variables of "overweight" and "obese" were significant prognostic factors for biochemical recurrence. In multivariate analysis models including PSA density [hazard ratio (HR) 1.8, p = 0.01], extraprostatic extension (HR 2.0, p < 0.001), Gleason score (HR 1.7, p = 0.01), surgical margin positivity (HR 2.46, p < 0.001), and lymphovascular invasion (HR 2.53, p < 0.001), the categorical variables of "overweight" (HR 1.6, p = 0.03) and "obese" (HR 1.76, p = 0.035) were prognostic factors for biochemical recurrence. Conclusion The obesity status of patients with prostate cancer as "overweight" and "obese" was a risk factor for biochemical recurrence after adjusting for other clinicopathological factors.
引用
收藏
页码:403 / 410
页数:8
相关论文
共 50 条
  • [41] Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy
    Fuchsjaeger, Michael H.
    Shukla-Dave, Amita
    Hricak, Hedvig
    Wang, Liang
    Touijer, Karim
    Donohue, John F.
    Eastham, James A.
    Kattan, Michael W.
    BJU INTERNATIONAL, 2009, 104 (03) : 315 - 320
  • [42] WWOX Polymorphisms as Predictors of the Biochemical Recurrence of Localized Prostate Cancer after Radical Prostatectomy
    Lin, Chia -Yen
    Wang, Chun -Li
    Wang, Shian-Shiang
    Yang, Cheng-Kuang
    Li, Jian-Ri
    Chen, Chuan-Shu
    Hung, Sheng-Chun
    Chiu, Kun-Yuan
    Cheng, Chen-Li
    Ou, Yen-Chuan
    Yang, Shun-Fa
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2023, 20 (07): : 969 - 975
  • [43] Tumor laterality does not predict biochemical prostate cancer recurrence after radical prostatectomy
    Mouraviev, Vladimir
    Sun, Leon
    Madden, John F.
    Mayes, Janice M.
    Moul, Judd W.
    George, Daniel J.
    Febbo, Philip G.
    Polascik, Thomas J.
    JOURNAL OF ENDOUROLOGY, 2007, 21 : A216 - A216
  • [44] Survival analysis of patients with prostate cancer and unfavorable risk factors treated with radical prostatectomy and salvage radiotherapy after biochemical recurrence and persistence
    Barbas Bernardos, G.
    Herranz Amo, F.
    Gonzalez San Segundo, C.
    Cano Velasco, J.
    Subira Rios, D.
    Moralejo Garate, M.
    Mayor de Castro, J.
    Aragon Chamizo, J.
    Hernandez Fernandez, C.
    ACTAS UROLOGICAS ESPANOLAS, 2020, 44 (10): : 701 - 707
  • [45] Defining biochemical recurrence of prostate cancer after radical prostatectomy: A proposal for a standardized definition
    Stephenson, AJ
    Scardino, PT
    Eastham, JA
    Lilja, H
    Bianco, FJ
    Dotan, ZA
    Kattan, MW
    JOURNAL OF UROLOGY, 2005, 173 (04): : 183 - 183
  • [46] Defining biochemical recurrence of prostate cancer after radical prostatectomy: A proposal for standardized definition
    Stephenson, Andrew J.
    Kattan, Michael W.
    Eastham, James A.
    Dotan, Zohar A.
    Bianco, Fernando J., Jr.
    Lilja, Hans
    Scardino, Peter T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) : 3973 - 3978
  • [47] Genetic risk score to predict biochemical recurrence after radical prostatectomy in prostate cancer: prospective cohort study
    Oh, Jong Jin
    Park, Seunghyun
    Lee, Sang Eun
    Hong, Sung Kyu
    Lee, Sangchul
    Kim, Tae Jin
    Lee, In Jae
    Ho, Jin-Nyoung
    Yoon, Sungroh
    Byun, Seok-Soo
    ONCOTARGET, 2017, 8 (44) : 75979 - 75988
  • [48] VALIDATION OF EAU RISK GROUPS FOR BIOCHEMICAL RECURRENCE AFTER RADIOTHERAPY AND RADICAL PROSTATECTOMY FOR PREDICTION OF PROSTATE CANCER MORTALITY
    Falagario, Ugo
    Bogdanovic, Darko
    Bjornebo, Lars
    Abbadi, Ahmad
    Valdman, Alexander
    Eklund, Martin
    Nordstrom, Tobias
    Aly, Markus
    Gronberg, Henrik
    Lantz, Anna
    Wiklund, Peter
    JOURNAL OF UROLOGY, 2023, 209 : E214 - E215
  • [49] Is PSA Still the Best Predictor for Biochemical Recurrence after Radical Prostatectomy in High-Risk Prostate Cancer?
    Akan, Serkan
    Guner, Numan Dogu
    Ediz, Caner
    Sahin, Aytac
    Verit, Ayhan
    JOURNAL OF INVESTIGATIVE SURGERY, 2022, 35 (10) : 1733 - 1738
  • [50] The Impact of Pathologic Upgrading of Gleason Score 7 Prostate Cancer on the Risk of the Biochemical Recurrence after Radical Prostatectomy
    Park, Juhyun
    Yoo, Sangjun
    Cho, Min Chul
    Cho, Min Hyun
    Jeong, Chang Wook
    Ku, Ja Hyeon
    Kwak, Cheol
    Kim, Hyeon Hoe
    Jeong, Hyeon
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018